Inventiva (IVA) Retained Earnings (2018 - 2025)
Inventiva's (IVA) quarterly Retained Earnings came in at -$3.2 million in Q4 2025, down 174.58% year-on-year from $4.3 million in Q4 2024, and up 100.0% quarter-over-quarter from -$199.1 billion in Q2 2025.
Inventiva (IVA) Retained Earnings (2018 - 2025) Analysis & Trends
Inventiva's Retained Earnings history runs 8 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 174.58% year-over-year to -$3.2 million in Q4 2025; TTM through Dec 2025 was -$3.2 million, a 174.58% decrease from a year earlier, with the FY2025 full-year figure at -$3.2 million, down 174.58% from the prior year.
- Retained Earnings advanced to -$3.2 million in Q4 2025 per IVA's latest filing, from -$199.1 billion in the prior quarter.
- Across five years, Retained Earnings topped out at -$190842.4 in Q4 2023 and bottomed at -$199.1 billion in Q2 2025.
- The 5-year median for Retained Earnings is -$6.9 million (2021), against an average of -$28.7 billion.
- Biggest YoY gain for Retained Earnings was 174.58% in 2025; the steepest drop was 12802989.94% in 2025.
- Year by year, Retained Earnings stood at -$56.8 billion in 2021, then surged by 44.63% to -$31.4 billion in 2022, then soared by 100.0% to -$191517.3 in 2023, then slumped by 507.62% to -$1.2 million in 2024, then plunged by 174.58% to -$3.2 million in 2025.
- Per Business Quant, the three latest IVA Retained Earnings figures stand at -$3.2 million (Q4 2025), -$199.1 billion (Q2 2025), and -$1.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.20 Mn |
| Jun 30, 2025 | -199.09 Bn |
| Dec 31, 2024 | -1.16 Mn |
| Jun 30, 2024 | -1.56 Mn |
| Dec 31, 2023 | -191,517.30 |
| Oct 11, 2023 | -190,842.37 |
| Jun 30, 2022 | -31.44 Bn |
| Dec 31, 2021 | -56.78 Bn |
| Jun 30, 2021 | -27.86 Mn |
| Mar 31, 2021 | -10.66 Mn |
| Dec 31, 2020 | -40.08 Mn |
| Dec 31, 2019 | -16.24 Mn |
| Dec 31, 2018 | 19.32 Mn |